SCHEMBL3479957

SCHEMBL3479957

CN1CCN(c2ccc(Cl)cc2)c2ccc(-c3ncns3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.41
HRH4 Q9H3N8 3/20 0.36
HTR6 P50406 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
POLB P06746 1/20 0.34
BRD4 O60885 5/20 0.34
BRD2 P25440 4/20 0.34
BRD3 Q15059 3/20 0.34
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
PTK2B Q14289 1/20 0.33
CXCR1 P25024 2/20 0.32
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479738 0.89 SCN9A (0.43) SCN9AHRH4MAPKAPK2GAAMAPT
SCHEMBL3479711 0.89 SCN9A (0.42) SCN9AHRH4POLBGAAMAPT
SCHEMBL3227917 0.87 SCN9A (0.40) SCN9AGAAMAPTKDM4EMAPK1
SCHEMBL3229546 0.85 SCN9A (0.39) SCN9AHRH4GAAMAPTKDM4E
SCHEMBL3479736 0.84 HTR3A (0.41) SCN9AHRH4HTR6HRH3MAPT
SCHEMBL3232833 0.83 SCN9A (0.41) SCN9AHRH4HTR6HRH3MAPKAPK2
SCHEMBL3479808 0.80 SCN9A (0.41) SCN9AHRH4HTR6HRH3MAPKAPK2
SCHEMBL3479501 0.80 SLC6A2 (0.45) SCN9AHRH4HTR6HRH3MAPKAPK2
SCHEMBL3479700 0.80 SCN9A (0.46) SCN9AHRH4HTR6HRH3MAPKAPK2
SCHEMBL3240462 0.78 SCN9A (0.46) SCN9AHRH4HTR6HRH3MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885HRH4 90/4885HTR6 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.